The Lyme community will greatly benefit from his enthusiasm, open minded yet scientific approach, and deep knowledge of Lyme disease.
Greenwich, Connecticut (PRWEB)
September 22, 2017
Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness, today announced the appointment of Timothy J. Sellati, Ph.D. as its Chief Scientific Officer.
A noted immunologist and microbiologist, Dr. Sellati has more than 20 years of research experience with Lyme and other tick-borne diseases. He has published more than 20 peer-reviewed papers and is frequently invited to speak about tick-borne disease and his cutting-edge research at national scientific meetings.
Today he is considered one of the nation’s foremost experts in the search to understand infectious disease processes and improve treatments of patients suffering from those illnesses.
Dr. Sellati joins GLA from Southern Research Institute in Alabama where he has served as a Senior Research Fellow and Chair of its Infectious Diseases Department. In this capacity he has led infectious disease researchers working to identify novel mechanisms, targets, and strategies for the prevention and treatment of both bacterial and viral infectious diseases that occur throughout the world.
His recent research has focused on Lyme immunity, vaccine development against biological threat agents and emerging pathogens, and persister formation. He is particularly interested in why Lyme disease causes some mild symptoms with no lasting effects in some people, while others go on to develop persistent, debilitating symptoms such as severe musculoskeletal pain, cardiac failure, and neural impairment, including memory and cognitive loss.
“Tim brings a depth and breadth of knowledge of Lyme disease, broad experience in research, and a strong commitment to help individuals who have been afflicted by tick-borne diseases,” said GLA’s CEO Scott Santarella. “We are particularly impressed by Tim’s creative, innovative thinking, and his enthusiasm for working collaboratively with GLA’s Board of Directors, Scientific Advisory Board, staff members and constituents to shift the paradigm of Lyme disease,”…